Company news
Trevi Therapeutics, Inc. news in 2020
Trevi Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Trevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update
November 10, 2020
Trevi Therapeutics to Present at Stifel Healthcare Conference
November 9, 2020
Trevi Therapeutics to Report Q3 2020 Financial Results on November 11
November 3, 2020
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™
October 20, 2020
Trevi Therapeutics Announces the Hiring of Key Talent
October 12, 2020
Trevi Therapeutics to Present at H.C. Wainwright Global Investment Conference
September 8, 2020
Trevi Therapeutics Announces Second Quarter 2020 Financial Results and Business Update
August 12, 2020
Trevi Therapeutics to Report Q2 2020 Financial Results on August 13
August 5, 2020
Trevi Therapeutics to Present at BTIG Virtual Biotechnology Conference
August 4, 2020
Trevi Therapeutics Announces Positive Outcome of the Sample Size Re-Estimation Analysis in PRISM Trial for Severe Pruritus in Patients With Prurigo Nodularis
July 12, 2020
Trevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors
June 29, 2020
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference
June 16, 2020
Trevi Therapeutics to Hold Virtual 2020 Annual Meeting of Stockholders
May 28, 2020
Trevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update
May 6, 2020
Trevi Therapeutics to present at needham healthcare conference
April 7, 2020
Trevi Therapeutics announces fourth quarter and year end 2019 financial results and corporate update
March 15, 2020
Trevi Therapeutics to Present at SVB Leerink Healthcare Conference
February 19, 2020
Trevi Therapeutics Announces Election of James V. Cassella, Ph.D. to Board of Directors
February 17, 2020